Rafik Ait Sarkouh

First-in-Human Study Testing a New Radioenhancer Using Nanoparticles (NBTXR3) Activated by Radiation Therapy in Patients with Locally Advanced Soft Tissue Sarcomas

Sylvie Bonvalot, C. Le Péchoux, Thierry de Baère et al. · Clinical Cancer Research · 2016 · 234 citations

Medicine, Oncology, Radiation Oncology +17

A new delivery system for auristatin in STxB-drug conjugate therapy

Cornélie Batisse, Estelle Dransart, Rafik Ait Sarkouh et al. · European Journal of Medicinal Chemistry · 2015 · 38 citations

Pharmacy, Pharmaceutics, Pharmacology +14

Final results from the phase I study expansion cohort of the selective FGFR inhibitor Debio 1,347 in patients with solid tumors harboring an FGFR gene fusion.

James M. Cleary, Gopa Iyer, Do‐Youn Oh et al. · Journal of Clinical Oncology · 2020 · 34 citations

Medicine, Oncology, Pharmacology +17

Effective antitumor therapy based on a novel antibody-drug conjugate targeting the Tn carbohydrate antigen

Christine Sedlik, Adèle Heitzmann, Sophie Viel et al. · OncoImmunology · 2016 · 24 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +17